In a groundbreaking clinical trial, researchers have successfully injected regenerative cells derived from human stem cells into the brains of patients with drug-resistant temporal lobe epilepsy. This experimental therapy, known as NRTX-1001, aims to restore brain balance and provide a non-destructive cure for seizures. Early results have shown a remarkable reduction of over 90% in seizure frequency among the initial patients who underwent this treatment. This innovative approach holds great potential for offering a solution to those suffering from epileptic seizures that do not respond to conventional treatments.

To know more: About the original article click here.